Dextranomer and Hyaluronate Derivatives (Deflux) and Insulin glargine and lixisenatide
Determining the interaction of Dextranomer and Hyaluronate Derivatives (Deflux) and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextranomer / sodium hyaluronate
Brand name: Solesta
Synonyms: Dextranomer and sodium hyaluronate
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextranomer and Hyaluronate Derivatives (Deflux)-Insulin glargine and lixisenatide Subcutaneous
- Dextranomer and Hyaluronate Derivatives (Deflux)-Insulin glargine, recombinant Subcutaneous
- Dextranomer and Hyaluronate Derivatives (Deflux)-Insulin glulisine
- Dextranomer and Hyaluronate Derivatives (Deflux)-Insulin Glulisine (Cartridges and Pens)
- Dextranomer and Hyaluronate Derivatives (Deflux)-Insulin Glulisine (Vials)
- Dextranomer and Hyaluronate Derivatives (Deflux)-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Dextranomer and Hyaluronate Derivatives (Solesta)
- Insulin glargine and lixisenatide-Dextranomer and sodium hyaluronate
- Insulin glargine and lixisenatide-Dextroamphetamine
- Insulin glargine and lixisenatide-Dextroamphetamine and amphetamine
- Insulin glargine and lixisenatide-Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Insulin glargine and lixisenatide-Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)